Form 8.3

Rathbones Group plc filed a Rule 8.3 disclosure dated 23/07/2026 showing holdings of 8,420,423 shares of Advanced Medical Solutions Group plc’s 5p Ordinary Shares, equal to 3.81%. The notice also reports recent sales of 2,830 shares at 280p and 50,000 shares at 279.50p per unit. This is a regulatory/position update and does not, by itself, indicate a change in bid terms.

Analysis

This reads more like registry noise than a signal on intrinsic value. A 3.8% institutional stake with a token trim is the kind of flow that often shows up when an event-driven book is rebalancing around index, liquidity, or mandate constraints rather than expressing a fresh view; the market should not infer a deal verdict from it alone.

The only real market mechanism here is takeover optionality: once a name is in a live Code process, every 8.3/8.1 disclosure affects who can block or facilitate an outcome, not operating performance. That means the stock can stay pinned by arb interest if a formal offer emerges, but absent a Rule 2.7 or additional stake changes, the disclosure should fade quickly and the share price should revert to fundamentals over days to weeks.

Contrarian takeaway: consensus may overstate the importance of a small partial sale. The more useful read is that a meaningful holder still has skin in the game, which can keep a floor under the target if a bid is being assembled, but also means any process could be slower and more fragile if holders disagree. Falsifier for the event case would be no follow-on disclosures within 1-3 weeks and no formal offer deadline; in that scenario, this is just a data point, not a thesis change.

Key Decisions for Investors

• No immediate standalone trade in the target on this disclosure alone; wait for a Rule 2.7 announcement, another 8.3, or a formal deadline before taking event risk.
• If already long the target in an arb book, keep position small and delta-hedged until there is evidence of a live process; the risk/reward is poor if this is only housekeeping flow.
• Set alerts for any further 1%+ ownership moves by large holders or a crossing of the 4%/5% thresholds, which would materially improve the signal quality on bid support or distribution.
• If a formal bid appears, consider a short-duration merger-arb long in the target versus a UK small-cap healthcare basket short; until then, avoid paying away premium for optionality.